{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:52:38Z","timestamp":1760057558106,"version":"build-2065373602"},"reference-count":143,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T00:00:00Z","timestamp":1739145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Stroke is a devastating complication of cardiovascular interventions. Intraprocedural stroke is a well-documented and feared risk of cardiac percutaneous transcatheter procedures. If clinically significant strokes are absent, silent strokes remain the next in line to pose large concerns related to future cognitive decline, stroke risk, and overall increased morbidity and mortality. Cerebral protection devices (CPD) developed overtime aim to neutralize this risk through either a capture-based filter or a deflector mechanism. Many CPDs exist currently, each one unique, with varying degrees of evidence. The adoption of CPDs has allowed cardiac percutaneous transcatheter procedures to be carried out in patients with high thromboembolic risks who may have historically been discommended. Though skewed towards certain devices and transcatheter procedures, a large body of evidence is still present across other devices and procedures. This review will discuss clinical importance and respective stroke rates, updated evidence surrounding CPDs, differing opinions across types of CPDs, cost benefits, and what lies ahead for CPDs within the realm of procedures undertaken in cardiac catheterization laboratories.<\/jats:p>","DOI":"10.3390\/medicina61020305","type":"journal-article","created":{"date-parts":[[2025,2,10]],"date-time":"2025-02-10T06:43:07Z","timestamp":1739169787000},"page":"305","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuroprotection Devices in Cardiac Catheterization Laboratories: Does It Sufficiently Protect Our Patients?"],"prefix":"10.3390","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-1464-4315","authenticated-orcid":false,"given":"Clement","family":"Tan","sequence":"first","affiliation":[{"name":"Department of Cardiology, Mackay Base Hospital, Mackay, QLD 4740, Australia"},{"name":"Division of Medicine, Cairns Hospital, Cairns, QLD 4870, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark Daniel","family":"Higgins","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mackay Base Hospital, Mackay, QLD 4740, Australia"},{"name":"The Prince Charles Hospital, Chermside, QLD 4032, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaikunthan","family":"Thanabalasingam","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mackay Base Hospital, Mackay, QLD 4740, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaminda","family":"Sella Kapu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mackay Base Hospital, Mackay, QLD 4740, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihua","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Mackay Base Hospital, Mackay, QLD 4740, Australia"},{"name":"College of Medicine and Dentistry, James Cook University, Townsville, QLD 4814, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Mohyeldin, M., Mohamed, F.O., Mustafa, A., Allu, S., and Shrivastava, S. (2024). F. Mason Sones Jr.: The Serendipitous Discovery of Coronary Angiography and Its Lasting Impact on Cardiology. Cureus, 16.","DOI":"10.7759\/cureus.61080"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Canfield, J., and Totary-Jain, H. (2018). 40 Years of Percutaneous Coronary Intervention: History and Future Directions. J. Pers. Med., 8.","DOI":"10.3390\/jpm8040033"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1001\/jama.2021.2133","article-title":"Transcatheter Treatment of Valvular Heart Disease: A Review","volume":"325","author":"Davidson","year":"2021","journal-title":"JAMA"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.4244\/EIJ-D-22-00070","article-title":"Transcatheter interventions for heart failure","volume":"18","author":"Latib","year":"2023","journal-title":"EuroIntervention"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"I116","DOI":"10.1093\/eurheartj\/sum073","article-title":"Evolution of ablation techniques: From WPW to complex arrhythmias","volume":"9","author":"Wolpert","year":"2007","journal-title":"Eur. Heart J. Suppl."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.amjcard.2005.06.065","article-title":"Neurological Complications Following Percutaneous Coronary Interventions (A Report from the 2000\u20132001 New York State Angioplasty Registry)","volume":"96","author":"Wong","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ccd.29744","article-title":"SCAI expert consensus update on best practices in the cardiac catheterization laboratory","volume":"98","author":"Naidu","year":"2021","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1161\/CIR.0000000000000996","article-title":"Evidence-Based Practices in the Cardiac Catheterization Laboratory: A Scientific Statement From the American Heart Association","volume":"144","author":"Bangalore","year":"2021","journal-title":"Circulation"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/ccd.1067","article-title":"Complications of cardiac catheterization in the current era: A single-center experience","volume":"52","author":"Chandrasekar","year":"2001","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_10","first-page":"65","article-title":"Risks and complications of coronary angiography: A comprehensive review","volume":"4","author":"Tavakol","year":"2012","journal-title":"Glob. J. Health Sci."},{"key":"ref_11","first-page":"e574","article-title":"2011 ACCF\/AHA\/SCAI Guideline for Percutaneous Coronary Intervention","volume":"124","author":"Levine","year":"2011","journal-title":"Circulation"},{"key":"ref_12","first-page":"e18","article-title":"2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Mortazavi, B.J., Bucholz, E.M., Desai, N.R., Huang, C., Curtis, J.P., Masoudi, F.A., Shaw, R.E., Negahban, S.N., and Krumholz, H.M. (2019). Comparison of Machine Learning Methods With National Cardiovascular Data Registry Models for Prediction of Risk of Bleeding After Percutaneous Coronary Intervention. JAMA Netw. Open, 2.","DOI":"10.1001\/jamanetworkopen.2019.6835"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jcin.2013.03.020","article-title":"Enhanced mortality risk prediction with a focus on high-risk percutaneous coronary intervention: Results from 1,208,137 procedures in the NCDR (National Cardiovascular Data Registry)","volume":"6","author":"Brennan","year":"2013","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jcin.2010.04.006","article-title":"Comparison between the NERS (New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting","volume":"3","author":"Chen","year":"2010","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.apmr.2013.10.032","article-title":"Incidence, Prevalence, Costs, and Impact on Disability of Common Conditions Requiring Rehabilitation in the United States: Stroke, Spinal Cord Injury, Traumatic Brain Injury, Multiple Sclerosis, Osteoarthritis, Rheumatoid Arthritis, Limb Loss, and Back Pain","volume":"95","author":"Ma","year":"2014","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Brilakis, E.S. (2014). 3\u2014The Basics: Timing, Dual Injection, Studying the Lesion, Access, Anticoagulation, Guide Support, Trapping. Manual of Coronary Chronic Total Occlusion Interventions, Academic Press.","DOI":"10.1016\/B978-0-12-420129-3.00003-9"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1038\/modpathol.2010.74","article-title":"Hydrophilic polymer emboli: An under-recognized iatrogenic cause of ischemia and infarct","volume":"23","author":"Mehta","year":"2010","journal-title":"Mod. Pathol."},{"key":"ref_19","first-page":"263","article-title":"Thrombus formation on guide wires during routine PTCA procedures: A scanning electron microscopic evaluation","volume":"18","author":"Gobeil","year":"2002","journal-title":"Can. J. Cardiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jvir.2006.12.733","article-title":"Thrombus formation at the surface of guide-wire models: Effects of heparin-releasing or heparin-exposing surface coatings","volume":"18","author":"Aldenhoff","year":"2007","journal-title":"J. Vasc. Interv. Radiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/eurheartj\/ehad836","article-title":"Merging machine learning and patient preference: A novel tool for risk prediction of percutaneous coronary interventions","volume":"45","author":"Hamilton","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1001\/jama.2016.10302","article-title":"Effect of a Cerebral Protection Device on Brain Lesions Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis: The CLEAN-TAVI Randomized Clinical Trial","volume":"316","author":"Haussig","year":"2016","journal-title":"JAMA"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Zahid, S., Ullah, W., Zia Khan, M., Faisal Uddin, M., Rai, D., Abbas, S., Usman Khan, M., Hussein, A., Salama, A., and Bandyopadhyay, D. (2023). Cerebral Embolic Protection during Transcatheter Aortic Valve Implantation: Updated Systematic Review and Meta-Analysis. Curr. Probl. Cardiol., 48.","DOI":"10.1016\/j.cpcardiol.2022.101127"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.amjcard.2021.01.023","article-title":"Meta-Analysis of Usefulness of Cerebral Embolic Protection During Transcatheter Aortic Valve Implantation","volume":"146","author":"Ahmad","year":"2021","journal-title":"Am. J. Cardiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jcin.2020.09.047","article-title":"The Use and Outcomes of Cerebral Protection Devices for Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement in Clinical Practice","volume":"14","author":"Stachon","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Kaur, A., Dhaliwal, A., Sohal, S., Kliger, C., Velagapudi, P., Basman, C., and Dominguez, A.C. (2022). TCT-327 Clinical and Radiographic Measures of Stroke-Related Outcomes With Cerebral Embolic Protection Devices During TAVR: A Meta-Analysis. J. Am. Coll. Cardiol., 80.","DOI":"10.1016\/j.jacc.2022.08.383"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1586\/erc.12.78","article-title":"Stroke in patients undergoing coronary angiography and percutaneous coronary intervention: Incidence, predictors, outcome and therapeutic options","volume":"10","author":"Werner","year":"2012","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Haussig, S., Linke, A., and Mangner, N. (2020). Cerebral Protection Devices during Transcatheter Interventions: Indications, Benefits, and Limitations. Curr. Cardiol. Rep., 22.","DOI":"10.1007\/s11886-020-01335-9"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1002\/ehf2.14008","article-title":"Elderly aortic stenosis patients\u2019 perspectives on treatment goals in transcatheter aortic valvular replacement","volume":"9","author":"Sugiura","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1161\/CIRCULATIONAHA.112.092544","article-title":"Cerebral Embolization During Transcatheter Aortic Valve Implantation","volume":"126","author":"Kahlert","year":"2012","journal-title":"Circulation"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4244\/EIJ-D-23-00166","article-title":"Cerebral embolic protection during transcatheter heart interventions","volume":"19","author":"Kapadia","year":"2023","journal-title":"EuroIntervention"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Elkaryoni, A., and Saad, M. (2024). Stroke in Patients Undergoing Transcatheter Aortic Valve Replacement: Embracing the Unpredictable. J. Am. Heart Assoc., 13.","DOI":"10.1161\/JAHA.124.036240"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/j.jacc.2020.09.595","article-title":"STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement","volume":"76","author":"Carroll","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Vlastra, W., Jimenez-Quevedo, P., Tch\u00e9tch\u00e9, D., Chandrasekhar, J., de Brito, F.S., Barbanti, M., Kornowski, R., Latib, A., D\u2019Onofrio, A., and Ribichini, F. (2019). Predictors, Incidence, and Outcomes of Patients Undergoing Transfemoral Transcatheter Aortic Valve Implantation Complicated by Stroke. Circ. Cardiovasc. Interv., 12.","DOI":"10.1161\/CIRCINTERVENTIONS.118.007546"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Guedeney, P., Mehran, R., Collet, J.-P., Claessen, B.E., ten Berg, J., and Dangas, G.D. (2019). Antithrombotic Therapy After Transcatheter Aortic Valve Replacement. Circ. Cardiovasc. Interv., 12.","DOI":"10.1161\/CIRCINTERVENTIONS.118.007411"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1016\/j.jcin.2023.10.021","article-title":"Long-Term Risk of Stroke After Transcatheter Aortic Valve Replacement","volume":"16","author":"Okuno","year":"2023","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Butala, N.M., Kapadia, S.R., Secemsky, E.A., Gallup, D., Kosinski, A.S., Vemulapalli, S., Messenger, J.C., Yeh, R.W., and Cohen, D.J. (2024). Impact of Cerebral Embolic Protection Devices on Disabling Stroke After TAVR: Updated Results From the STS\/ACC TVT Registry. Circ. Cardiovasc. Interv., 17.","DOI":"10.1161\/CIRCINTERVENTIONS.123.013697"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"129","DOI":"10.4244\/EIJV8I1A20","article-title":"Risk of stroke after transcatheter aortic valve implantation (TAVI): A meta-analysis of 10,037 published patients","volume":"8","author":"Eggebrecht","year":"2012","journal-title":"EuroIntervention"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jacc.2016.10.023","article-title":"Protection Against Cerebral Embolism During Transcatheter Aortic Valve Replacement","volume":"69","author":"Kapadia","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jacc.2017.06.045","article-title":"Clinical Outcomes With a Repositionable Self-Expanding Transcatheter Aortic Valve Prosthesis: The International FORWARD Study","volume":"70","author":"Grube","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients","volume":"380","author":"Mack","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.jacc.2016.05.065","article-title":"Predictors of Early Cerebrovascular Events in Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement","volume":"68","author":"Auffret","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1093\/eurheartj\/ehy847","article-title":"Rate of peri-procedural stroke observed with cerebral embolic protection during transcatheter aortic valve replacement: A patient-level propensity-matched analysis","volume":"40","author":"Seeger","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1161\/CIRCULATIONAHA.120.052874","article-title":"Cerebral Embolic Protection and Outcomes of Transcatheter Aortic Valve Replacement: Results From the Transcatheter Valve Therapy Registry","volume":"143","author":"Butala","year":"2021","journal-title":"Circulation"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Preda, A., Montalto, C., Galasso, M., Munaf\u00f2, A., Garofani, I., Baroni, M., Gigli, L., Vargiu, S., Varrenti, M., and Colombo, G. (2023). Fighting Cardiac Thromboembolism during Transcatheter Procedures: An Update on the Use of Cerebral Protection Devices in Cath Labs and EP Labs. Life, 13.","DOI":"10.3390\/life13091819"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1161\/01.STR.0000231641.55843.49","article-title":"Cerebral microembolism during cardiac catheterization and risk of acute brain injury: A prospective diffusion-weighted magnetic resonance imaging study","volume":"37","author":"Hamon","year":"2006","journal-title":"Stroke"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000047682","article-title":"Transcranial Doppler detection of cerebral microemboli during left heart catheterization","volume":"12","author":"Leclercq","year":"2001","journal-title":"Cerebrovasc. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1161\/01.STR.29.11.2367","article-title":"Transcranial Doppler detection of microemboli during percutaneous transluminal coronary angioplasty","volume":"29","author":"Bladin","year":"1998","journal-title":"Stroke"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/CIRCULATIONAHA.108.784504","article-title":"Periprocedural stroke and cardiac catheterization","volume":"118","author":"Hamon","year":"2008","journal-title":"Circulation"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.jacc.2003.11.033","article-title":"Characteristics of cerebrovascular accidents after percutaneous coronary interventions","volume":"43","author":"Dukkipati","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1161\/01.CIR.48.3.609","article-title":"The complications of coronary arteriography","volume":"48","author":"Adams","year":"1973","journal-title":"Circulation"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ccd.1810080103","article-title":"Complications associated with cardiac catheterization and angiography","volume":"8","author":"Kennedy","year":"1982","journal-title":"Cathet Cardiovasc. Diagn."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ccd.1810170103","article-title":"Coronary arteriography 1984\u20131987: A report of the Registry of the Society for Cardiac Angiography and Interventions. I. Results and complications","volume":"17","author":"Johnson","year":"1989","journal-title":"Catheter. Cardiovasc. Diagn."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jacc.2018.04.071","article-title":"Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization","volume":"72","author":"Head","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1253\/circj.72.51","article-title":"Asymptomatic acute ischemic stroke after primary percutaneous coronary intervention in patients with acute coronary syndrome might be caused mainly by manipulating catheters or devices in the ascending aorta, regardless of the approach to the coronary artery","volume":"72","author":"Murai","year":"2008","journal-title":"Circ. J."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.ahj.2011.07.021","article-title":"Cognitive decline and ischemic microlesions after coronary catheterization. A comparison to coronary artery bypass grafting","volume":"162","author":"Schwarz","year":"2011","journal-title":"Am. Heart J."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Chan, N., Dong, T., Sabbak, N., Xu, B., and Wang, T.K.M. (2023). Contemporary Review of Transcatheter Mitral Valve Interventions for Mitral Regurgitation. Life, 13.","DOI":"10.3390\/life13071511"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter Mitral-Valve Repair in Patients with Heart Failure","volume":"379","author":"Stone","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","article-title":"Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation","volume":"379","author":"Obadia","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.4244\/EIJY14M05_10","article-title":"Incidence, characteristics and functional implications of cerebral embolic lesions after the MitraClip procedure","volume":"10","author":"Blazek","year":"2015","journal-title":"EuroIntervention"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.4244\/EIJ-D-19-00602","article-title":"Stroke after transcatheter edge-to-edge mitral valve repair: A systematic review and meta-analysis","volume":"15","author":"Sousa","year":"2020","journal-title":"EuroIntervention"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/eurheartj\/ehy424","article-title":"Transcatheter mitral valve repair for functional mitral regurgitation using the Cardioband system: 1 year outcomes","volume":"40","author":"Nickenig","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"X48","DOI":"10.4244\/EIJV12SXA10","article-title":"Left atrial appendage closure: Patient, device and post-procedure drug selection","volume":"12","author":"Tzikas","year":"2016","journal-title":"EuroIntervention"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective Randomized Evaluation of the Watchman Left Atrial Appendage Closure Device in Patients With Atrial Fibrillation Versus Long-Term Warfarin Therapy: The PREVAIL Trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4244\/EIJ-D-19-00507","article-title":"Percutaneous left atrial appendage closure versus non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation and high bleeding risk","volume":"15","author":"Godino","year":"2020","journal-title":"EuroIntervention"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.jacc.2019.12.040","article-title":"The NCDR Left Atrial Appendage Occlusion Registry","volume":"75","author":"Freeman","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"124","DOI":"10.4244\/EIJ-D-16-00776","article-title":"Frequency and clinical course of cerebral embolism in patients undergoing transcatheter left atrial appendage closure","volume":"13","author":"Majunke","year":"2017","journal-title":"EuroIntervention"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.hrthm.2017.11.015","article-title":"Left atrial appendage angiography is associated with the incidence and number of magnetic resonance imaging-detected brain lesions after percutaneous catheter-based left atrial appendage closure","volume":"15","author":"Rillig","year":"2018","journal-title":"Heart Rhythm."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/ene.13129","article-title":"Peri-procedural silent cerebral infarcts after left atrial appendage occlusion","volume":"24","author":"Laible","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jacep.2019.11.017","article-title":"Feasibility of Left Atrial Appendage Occlusion in Left Atrial Appendage Thrombus: A Systematic Review","volume":"6","author":"Sharma","year":"2020","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/ccd.29161","article-title":"Cerebral protection in left atrial appendage closure in the presence of appendage thrombosis","volume":"97","author":"Boccuzzi","year":"2021","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Berg, J., Preda, A., Fierro, N., Marzi, A., Radinovic, A., Della Bella, P., and Mazzone, P. (2023). A Referral Center Experience with Cerebral Protection Devices: Challenging Cardiac Thrombus in the EP Lab. J. Clin. Med., 12.","DOI":"10.3390\/jcm12041549"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/j.1540-8167.2009.01509.x","article-title":"Transcranial Measurement of Cerebral Microembolic Signals During Endocardial Pulmonary Vein Isolation: Comparison of Three Different Ablation Techniques","volume":"20","author":"Sauren","year":"2009","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_76","first-page":"37","article-title":"MEDAFI-Trial (Micro-embolization during ablation of atrial fibrillation): Comparison of pulmonary vein isolation using cryoballoon technique vs. radiofrequency energy","volume":"13","author":"Neumann","year":"2010","journal-title":"EP Eur."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jacc.2011.04.010","article-title":"Incidence of Asymptomatic Intracranial Embolic Events After Pulmonary Vein Isolation: Comparison of Different Atrial Fibrillation Ablation Technologies in a Multicenter Study","volume":"58","author":"Deneke","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.jacep.2019.04.009","article-title":"Pulmonary Vein Isolation With Very High Power, Short Duration, Temperature-Controlled Lesions: The QDOT-FAST Trial","volume":"5","author":"Reddy","year":"2019","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/europace\/eut282","article-title":"Modified phased radiofrequency ablation of atrial fibrillation reduces the number of cerebral microembolic signals","volume":"16","author":"Zellerhoff","year":"2014","journal-title":"Europace"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jacep.2021.02.014","article-title":"Pulsed Field Ablation of Paroxysmal Atrial Fibrillation: 1-Year Outcomes of IMPULSE, PEFCAT, and PEFCAT II","volume":"7","author":"Reddy","year":"2021","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1111\/imj.14781","article-title":"Recent trends in cardiac electrophysiology and catheter ablation in New Zealand","volume":"50","author":"Foo","year":"2020","journal-title":"Intern. Med. J."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Ryad, R., Saad-Omer, S.M., Khan, F., Limbana, T., and Jahan, N. (2020). Does Catheter Ablation Lower the Long-Term Risk of Stroke and Mortality in Patients with Atrial Fibrillation? A Concise Review of the Current State of Knowledge. Cureus, 12.","DOI":"10.7759\/cureus.9701"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1540-8167.2012.02420.x","article-title":"3 Tesla MRI-detected brain lesions after pulmonary vein isolation for atrial fibrillation: Results of the MACPAF study","volume":"24","author":"Haeusler","year":"2013","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/j.hrthm.2009.07.007","article-title":"Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: A safe and efficacious periprocedural anticoagulation strategy","volume":"6","author":"Hussein","year":"2009","journal-title":"Heart Rhythm."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/CIRCEP.109.859116","article-title":"Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation","volume":"3","author":"Cappato","year":"2010","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1540-8167.2009.01650.x","article-title":"Long-term functional and neurocognitive recovery in patients who had an acute cerebrovascular event secondary to catheter ablation for atrial fibrillation","volume":"21","author":"Patel","year":"2010","journal-title":"J. Cardiovasc. Electrophysiol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(09)61755-4","article-title":"Catheter ablation of stable ventricular tachycardia before defibrillator implantation in patients with coronary heart disease (VTACH): A multicentre randomised controlled trial","volume":"375","author":"Kuck","year":"2010","journal-title":"Lancet"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1016\/j.hrthm.2011.05.017","article-title":"Incidence and predictors of major complications from contemporary catheter ablation to treat cardiac arrhythmias","volume":"8","author":"Bohnen","year":"2011","journal-title":"Heart Rhythm."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/CIRCULATIONAHA.116.025546","article-title":"Brain Emboli After Left Ventricular Endocardial Ablation","volume":"135","author":"Whitman","year":"2017","journal-title":"Circulation"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Calvert, P., Kollias, G., P\u00fcrerfellner, H., Narasimhan, C., Osorio, J., Lip, G.Y.H., and Gupta, D. (2023). Silent cerebral lesions following catheter ablation for atrial fibrillation: A state-of-the-art review. EP Eur., 25.","DOI":"10.1093\/europace\/euad151"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.5114\/aoms.2020.94747","article-title":"Cerebral microembolism during atrial fibrillation ablation can result from the technical aspects and mostly does not cause permanent neurological deficit","volume":"16","author":"Puz","year":"2020","journal-title":"Arch. Med. Sci."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Miyazaki, S., Watanabe, T., Kajiyama, T., Iwasawa, J., Ichijo, S., Nakamura, H., Taniguchi, H., Hirao, K., and Iesaka, Y. (2017). Thromboembolic Risks of the Procedural Process in Second-Generation Cryoballoon Ablation Procedures: Analysis From Real-Time Transcranial Doppler Monitoring. Circ. Arrhythm. Electrophysiol., 10.","DOI":"10.1161\/CIRCEP.117.005612"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Takami, M., Lehmann, H.I., Parker, K.D., Welker, K.M., Johnson, S.B., and Packer, D.L. (2016). Effect of Left Atrial Ablation Process and Strategy on Microemboli Formation During Irrigated Radiofrequency Catheter Ablation in an In Vivo Model. Circ. Arrhythmia Electrophysiol., 9.","DOI":"10.1161\/CIRCEP.115.003226"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/pace.12844","article-title":"Catheter Ablation of Ventricular Tachycardia in the Presence of an Old Endocavitary Thrombus Guided by Intracardiac Echocardiography","volume":"39","author":"Peichl","year":"2016","journal-title":"Pacing Clin. Electrophysiol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Heeger, C.H., Metzner, A., Schl\u00fcter, M., Rillig, A., Mathew, S., Tilz, R.R., Wohlmuth, P., Romero, M.E., Virmani, R., and Fink, T. (2018). Cerebral Protection During Catheter Ablation of Ventricular Tachycardia in Patients With Ischemic Heart Disease. J. Am. Heart Assoc., 7.","DOI":"10.1161\/JAHA.118.009005"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jacep.2022.01.001","article-title":"Use of Cerebral Protection Device in Patients Undergoing Ventricular Tachycardia Catheter Ablation","volume":"8","author":"Zachariah","year":"2022","journal-title":"JACC Clin. Electrophysiol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1016\/j.jcmg.2020.02.036","article-title":"3-Dimensional CT Planning for Cerebral Embolic Protection in Structural Interventions","volume":"13","author":"Kang","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.4244\/EIJ-D-22-00713","article-title":"Routine cerebral embolic protection in transcatheter aortic valve implantation: Rationale and design of the randomised British Heart Foundation PROTECT-TAVI trial","volume":"18","author":"Kharbanda","year":"2023","journal-title":"EuroIntervention"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/joic.12573","article-title":"Cerebral embolic protection systems for transcatheter aortic valve replacement","volume":"31","author":"Gasior","year":"2018","journal-title":"J. Interv. Cardiol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.carrev.2019.11.014","article-title":"Real-World Experience of the Sentinel Cerebral Protection Device: Insights From the FDA Manufacturer and User Facility Device Experience (MAUDE) Database","volume":"21","author":"Case","year":"2020","journal-title":"Cardiovasc. Revasc Med."},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Demir, O.M., Iannopollo, G., Mangieri, A., Ancona, M.B., Regazzoli, D., Mitomo, S., Colombo, A., Weisz, G., and Latib, A. (2018). The Role of Cerebral Embolic Protection Devices During Transcatheter Aortic Valve Replacement. Front. Cardiovasc. Med., 5.","DOI":"10.3389\/fcvm.2018.00150"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Cubero-Gallego, H., Pascual, I., Rozado, J., Ayesta, A., Hernandez-Vaquero, D., Diaz, R., Alperi, A., Avanzas, P., and Moris, C. (2019). Cerebral protection devices for transcatheter aortic valve replacement. Ann. Transl. Med., 7.","DOI":"10.21037\/atm.2019.09.25"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJMoa2204961","article-title":"Cerebral Embolic Protection during Transcatheter Aortic-Valve Replacement","volume":"387","author":"Kapadia","year":"2022","journal-title":"New Engl. J. Med."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"499","DOI":"10.4244\/EIJV12I4A84","article-title":"Filter-based cerebral embolic protection with transcatheter aortic valve implantation: The randomised MISTRAL-C trial","volume":"12","author":"Ahmad","year":"2016","journal-title":"EuroIntervention"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/jamacardio.2024.4278","article-title":"Cerebral Embolic Protection by Geographic Region: A Post Hoc Analysis of the PROTECTED TAVR Randomized Clinical Trial","volume":"10","author":"Makkar","year":"2024","journal-title":"JAMA Cardiol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jcin.2019.11.017","article-title":"First-in-Man Study Evaluating the Emblok Embolic Protection System During Transcatheter Aortic Valve Replacement","volume":"13","author":"Latib","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jcin.2019.12.013","article-title":"Cerebral Embolic Protection: Finding a Black Cat in a Coal Cellar","volume":"13","author":"Lansky","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_108","doi-asserted-by":"crossref","unstructured":"Kaur, A., Dhaliwal, A.S., Sohal, S., Gwon, Y., Gupta, S., Bhatia, K., Dominguez, A.C., Basman, C., and Tamis-Holland, J. (2024). Role of Cerebral Embolic Protection Devices in Patients Undergoing Transcatheter Aortic Valve Replacement: An Updated Meta-Analysis. J. Am. Heart Assoc., 13.","DOI":"10.1161\/JAHA.123.030587"},{"key":"ref_109","doi-asserted-by":"crossref","unstructured":"Pasupati, S. (2020). TCT CONNECT-458 Clinical Performance of a Total Embolic Protection Device: Results of the Emboliner SafePass 2 Study. J. Am. Coll. Cardiol., 76.","DOI":"10.1016\/j.jacc.2020.09.487"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Lansky, A.J. (2023). B-50 | Full-Body Embolic Protection During Transcatheter Aortic Valve Replacement: The Protect the Head-to-Head Study, a Pivotal, Randomized Study Comparing the Emboliner Embolic Protection Catheter to the Sentinel CPS. J. Soc. Cardiovasc. Angiogr. Interv., 2.","DOI":"10.1016\/j.jscai.2023.100772"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1093\/ejcts\/ezx457","article-title":"Embolic protection devices for transcatheter aortic valve replacement","volume":"53","author":"Gallo","year":"2017","journal-title":"Eur. J. Cardio-Thorac. Surg."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.athoracsur.2015.03.119","article-title":"Intraaortic Protection From Embolization in Patients Undergoing Transaortic Transcatheter Aortic Valve Implantation","volume":"100","author":"Wendt","year":"2015","journal-title":"Ann. Thorac. Surg."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.jcin.2014.04.019","article-title":"Feasibility and Exploratory Efficacy Evaluation of the Embrella Embolic Deflector System for the Prevention of Cerebral Emboli in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTAVI-C Pilot Study","volume":"7","author":"Kahlert","year":"2014","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/eurheartj\/ehv191","article-title":"A prospective randomized evaluation of the TriGuard\u2122 HDH embolic DEFLECTion device during transcatheter aortic valve implantation: Results from the DEFLECT III trial","volume":"36","author":"Lansky","year":"2015","journal-title":"Eur. Heart J."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"590","DOI":"10.4244\/EIJ-D-22-00238","article-title":"Safety and performance of a novel cerebral embolic protection device for transcatheter aortic valve implantation: The PROTEMBO C Trial","volume":"18","author":"Jagielak","year":"2022","journal-title":"EuroIntervention"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e264","DOI":"10.4244\/EIJ-D-23-00743","article-title":"Final report of the PROTEMBO C Trial: A prospective evaluation of a novel cerebral protection device during TAVI","volume":"20","author":"Fezzi","year":"2024","journal-title":"EuroIntervention"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Scheinert, D., Reimers, B., Cremonesi, A., Schmidt, A., Sievert, H., Rohde, S., Schofer, J., Mudra, H.G., Bosiers, M., and Zeller, T. (2017). Independent Modular Filter for Embolic Protection in Carotid Stenting. Circ. Cardiovasc. Interv., 10.","DOI":"10.1161\/CIRCINTERVENTIONS.116.004244"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"e948","DOI":"10.4244\/EIJ-D-23-00465","article-title":"First-in-human study of the CAPTIS embolic protection system during transcatheter aortic valve replacement","volume":"19","author":"Danenberg","year":"2023","journal-title":"EuroIntervention"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4244\/EIJY15M04_01","article-title":"Safety and performance of a novel embolic deflection device in patients undergoing transcatheter aortic valve replacement: Results from the DEFLECT I study","volume":"11","author":"Baumbach","year":"2015","journal-title":"EuroIntervention"},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Samim, M., Hendrikse, J., Agostoni, P., Van Der Worp, B., Budde Ricardo, P., Nijhoff, F., Ramjankhan, F., Doevendans Pieter, A., and Stella Pieter, R. (2015). CRT-809 TriGuard\u2122 HD Embolic Deflection Device For Cerebral Protection During Transcatheter Aortic Valve Replacement: Results: Of The Deflect II Trial. JACC Cardiovasc. Interv., 8.","DOI":"10.1016\/j.jcin.2014.12.198"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1093\/eurheartj\/ehab213","article-title":"A randomized evaluation of the TriGuard\u2122 HDH cerebral embolic protection device to Reduce the Impact of Cerebral Embolic LEsions after TransCatheter Aortic Valve ImplanTation: The REFLECT I trial","volume":"42","author":"Lansky","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jcin.2020.11.011","article-title":"Randomized Evaluation of TriGuard 3 Cerebral Embolic Protection After Transcatheter Aortic Valve Replacement: REFLECT II","volume":"14","author":"Nazif","year":"2021","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ahj.2017.12.008","article-title":"Topographical distribution of perioperative cerebral infarction associated with transcatheter aortic valve implantation","volume":"197","author":"Fanning","year":"2018","journal-title":"Am. Heart J."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/ccd.27323","article-title":"Complete filter-based cerebral embolic protection with transcatheter aortic valve replacement","volume":"91","author":"Kroon","year":"2018","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_125","doi-asserted-by":"crossref","unstructured":"Alkhouli, M., Ganz, M., Mercaldi, K., McGovern, A., Griffiths, R., and Kapadia, S. (2021). TCT-305 Cost-Effectiveness of Cerebral Embolic Protection With the SENTINEL Device in Transcatheter Aortic Valve Replacement: A US Medicare Payer Perspective. J. Am. Coll. Cardiol., 78.","DOI":"10.1016\/j.jacc.2021.09.1158"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"606","DOI":"10.25122\/jml-2021-0361","article-title":"The economic burden of stroke: A systematic review of cost of illness studies","volume":"14","author":"Strilciuc","year":"2021","journal-title":"J. Med. Life"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S1474-4422(24)00369-7","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990\u20132021: A systematic analysis for the Global Burden of Disease Study 2021","volume":"23","author":"Feigin","year":"2024","journal-title":"Lancet Neurol."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/14779072.2024.2385989","article-title":"Cerebral embolic protection for stroke prevention during transcatheter aortic valve replacement","volume":"22","author":"Basit","year":"2024","journal-title":"Expert. Rev. Cardiovasc. Ther."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/2396987319883160","article-title":"Economic burden of stroke across Europe: A population-based cost analysis","volume":"5","author":"Violato","year":"2020","journal-title":"Eur. Stroke J."},{"key":"ref_130","doi-asserted-by":"crossref","unstructured":"Girotra, T., Lekoubou, A., Bishu, K.G., and Ovbiagele, B. (2020). A contemporary and comprehensive analysis of the costs of stroke in the United States. J. Neurol. Sci., 410.","DOI":"10.1016\/j.jns.2019.116643"},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1080\/24748706.2018.1539281","article-title":"Clinical and Economic Burden of Acute Ischemic Stroke Following Transcatheter Aortic Valve Replacement","volume":"3","author":"Alqahtani","year":"2019","journal-title":"Struct. Heart"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/ccd.29842","article-title":"Use and outcomes of cerebral embolic protection for transcatheter aortic valve replacement: A US nationwide study","volume":"98","author":"Khan","year":"2021","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/j.jcin.2020.05.039","article-title":"Ischemic Stroke With Cerebral Protection System During Transcatheter Aortic Valve Replacement","volume":"13","author":"Megaly","year":"2020","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Ubaid, A., Kennedy, K.F., Chhatriwalla, A.K., Saxon, J.T., Hart, A., Allen, K.B., Aberle, C., Shatla, I., Abumoawad, A., and Gunta, S.P. (2023). Site Variability in Cerebral Embolic Protection for Transcatheter Aortic Valve Implantation and Association With Outcomes. Struct. Heart, 7.","DOI":"10.1016\/j.shj.2023.100202"},{"key":"ref_135","doi-asserted-by":"crossref","unstructured":"Amoroso, E.M. (2023). Regional differences in the utilization and outcomes of cerebral embolic protection during transcatheter aortic valve replacement: An analysis of the National Inpatient Sample from 2017 through 2019. J. Comp. Eff. Res., 12.","DOI":"10.57264\/cer-2023-0010"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Shekhar, S., Krishnaswamy, A., Reed, G., Yun, J., Puri, R., and Kapadia, S. (2024). Early Outcomes With Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation. Structural Heart.","DOI":"10.1016\/j.amjcard.2024.02.013"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"Don\u00e0, C., Koschutnik, M., Nitsche, C., Winter, M.-P., Seidl, V., Siller-Matula, J., Mach, M., Andreas, M., Bartko, P., and Kammerlander, A.A. (2022). Cerebral Protection in TAVR\u2014Can We Do Without? A Real-World All-Comer Intention-to-Treat Study\u2014Impact on Stroke Rate, Length of Hospital Stay, and Twelve-Month Mortality. J. Pers. Med., 12.","DOI":"10.3390\/jpm12020320"},{"key":"ref_138","doi-asserted-by":"crossref","unstructured":"Jabagi, H., Shaw, R.E., Gharibeh, L., Tayal, R., Rahim, H., Kim, F., Zapolanski, A., and Grau, J.B. (2024). Patient Characteristics and Outcomes Associated with Sentinel Protection Device Use in Patients with Aortic Valve Disease Undergoing TAVR in a \u201cReal-World\u201d Setting. Rev. Cardiovasc. Med., 25.","DOI":"10.31083\/j.rcm2501003"},{"key":"ref_139","unstructured":"WHO Commission on Macroeconomics and Health (2001). Health. Macroeconomics and Health: Investing in Health for Economic Development\/Report of the Commission on Macroeconomics and Health, World Health Organization."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"e833","DOI":"10.1016\/S2214-109X(23)00162-6","article-title":"Determining the efficiency path to universal health coverage: Cost-effectiveness thresholds for 174 countries based on growth in life expectancy and health expenditures","volume":"11","author":"Drummond","year":"2023","journal-title":"Lancet Glob. Health"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1136\/heartjnl-2023-323359","article-title":"Stroke reduction by cerebral embolic protection devices in transcatheter aortic valve implantation: A systematic review and Bayesian meta-analysis","volume":"110","author":"Heuts","year":"2024","journal-title":"Heart"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1056\/NEJMoa2307447","article-title":"Transcatheter Aortic-Valve Replacement in Low-Risk Patients at Five Years","volume":"389","author":"Mack","year":"2023","journal-title":"New Engl. J. Med."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.jacc.2018.08.2172","article-title":"Stroke After Surgical Versus Transfemoral Transcatheter Aortic Valve Replacement in the PARTNER Trial","volume":"72","author":"Kapadia","year":"2018","journal-title":"J. Am. Coll. Cardiol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/2\/305\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:30:16Z","timestamp":1760027416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/61\/2\/305"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,10]]},"references-count":143,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["medicina61020305"],"URL":"https:\/\/doi.org\/10.3390\/medicina61020305","relation":{},"ISSN":["1648-9144"],"issn-type":[{"type":"electronic","value":"1648-9144"}],"subject":[],"published":{"date-parts":[[2025,2,10]]}}}